Skip to Content
Merck
  • Inhibition of stromelysin-1 by caffeic acid derivatives from a propolis sample from Algeria.

Inhibition of stromelysin-1 by caffeic acid derivatives from a propolis sample from Algeria.

Planta medica (2011-02-10)
Narimane Segueni, Abdulmagid Alabdul Magid, Martine Decarme, Salah Rhouati, Mesbah Lahouel, Frank Antonicelli, Catherine Lavaud, William Hornebeck
ABSTRACT

Stromelysin-1 (matrix metalloproteinase-3: MMP-3) occupies a central position in collagenolytic and elastolytic cascades, leading to cutaneous intrinsic and extrinsic aging. We screened extracts of a propolis sample from Algeria with the aim to isolate compounds able to selectively inhibit this enzyme. A butanolic extract (B (3)) of the investigated propolis sample was found to potently inhibit MMP-3 activity (IC (50) = 0.15 ± 0.03 µg/mL), with no or only weak activity on other MMPs. This fraction also inhibited plasmin amidolytic activity (IC (50) = 0.05 µg/mL) and impeded plasmin-mediated proMMP-3 activation. B (3) was fractionated by HPLC, and one compound, characterized by NMR and mass spectroscopy and not previously identified in propolis, i.e., (+)-chicoric acid, displayed potent IN VITRO MMP-3 inhibitory activity (IC (50) = 6.3 × 10 (-7) M). In addition, both caffeic acid and (+)-chicoric acid methyl ester present in fraction B (3) significantly inhibited UVA-mediated MMP-3 upregulation by fibroblasts.

MATERIALS
Product Number
Brand
Product Description

Supelco
(−)-Chicoric acid, analytical standard